Soken Chemical & Engineering Co., Ltd. (TYO:4972)
Japan · Delayed Price · Currency is JPY 3,515.00
+15.00 (0.43%)
Jun 15, 2026, 3:30 PM JST
TYO:4972 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 47,967 | 47,633 | 41,318 | 38,129 | 38,638 | |
Revenue Growth (YoY) | 0.70% | 15.28% | 8.36% | -1.32% | 22.69% |
Cost of Revenue | 31,869 | 31,856 | 28,774 | 27,952 | 28,376 |
Gross Profit | 16,098 | 15,777 | 12,544 | 10,177 | 10,262 |
Selling, General & Admin | 9,927 | 8,088 | 7,380 | 6,731 | 6,575 |
Research & Development | - | 1,302 | 1,335 | 1,404 | 1,455 |
Operating Expenses | 9,941 | 9,430 | 8,726 | 8,143 | 8,045 |
Operating Income | 6,157 | 6,347 | 3,818 | 2,034 | 2,217 |
Interest Expense | -110 | -133 | -124 | -20 | -52 |
Interest & Investment Income | 64 | 88 | 54 | 38 | 46 |
Currency Exchange Gain (Loss) | 98 | 6 | 148 | 71 | 422 |
Other Non Operating Income (Expenses) | 29 | 31 | 12 | 45 | 111 |
EBT Excluding Unusual Items | 6,238 | 6,339 | 3,908 | 2,168 | 2,744 |
Gain (Loss) on Sale of Investments | -312 | -52 | - | -56 | 58 |
Gain (Loss) on Sale of Assets | -6 | -42 | - | 5 | -1 |
Asset Writedown | -43 | -45 | -73 | -187 | -27 |
Other Unusual Items | -9 | -39 | -36 | 69 | -1 |
Pretax Income | 5,868 | 6,161 | 3,799 | 1,999 | 2,773 |
Income Tax Expense | 1,822 | 1,783 | 1,170 | 563 | 733 |
Earnings From Continuing Operations | 4,046 | 4,378 | 2,629 | 1,436 | 2,040 |
Net Income | 4,046 | 4,378 | 2,629 | 1,436 | 2,040 |
Net Income to Common | 4,046 | 4,378 | 2,629 | 1,436 | 2,040 |
Net Income Growth | -7.58% | 66.53% | 83.08% | -29.61% | -25.11% |
Shares Outstanding (Basic) | 17 | 17 | 17 | 17 | 16 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 17 | 16 |
Shares Change (YoY) | 0.10% | 0.13% | 0.18% | 0.19% | 0.19% |
EPS (Basic) | 243.88 | 264.15 | 158.83 | 86.91 | 123.71 |
EPS (Diluted) | 243.88 | 264.15 | 158.83 | 86.91 | 123.71 |
EPS Growth | -7.67% | 66.31% | 82.75% | -29.74% | -25.25% |
Free Cash Flow | 2,861 | 4,435 | 4,134 | -1,477 | 290 |
Free Cash Flow Per Share | 172.45 | 267.59 | 249.76 | -89.40 | 17.59 |
Dividend Per Share | - | 62.500 | 47.500 | 42.500 | 37.500 |
Dividend Growth | - | 31.58% | 11.77% | 13.33% | - |
Gross Margin | 33.56% | 33.12% | 30.36% | 26.69% | 26.56% |
Operating Margin | 12.84% | 13.33% | 9.24% | 5.33% | 5.74% |
Profit Margin | 8.43% | 9.19% | 6.36% | 3.77% | 5.28% |
Free Cash Flow Margin | 5.96% | 9.31% | 10.01% | -3.87% | 0.75% |
EBITDA | 8,649 | 8,753 | 6,056 | 3,922 | 4,120 |
EBITDA Margin | 18.03% | 18.38% | 14.66% | 10.29% | 10.66% |
D&A For EBITDA | 2,492 | 2,406 | 2,238 | 1,888 | 1,903 |
EBIT | 6,157 | 6,347 | 3,818 | 2,034 | 2,217 |
EBIT Margin | 12.84% | 13.33% | 9.24% | 5.33% | 5.74% |
Effective Tax Rate | 31.05% | 28.94% | 30.80% | 28.16% | 26.43% |